Genzyme Agrees to Sell Diagnostics Business to Sekisui Chemical

Genzyme Corp. said it agreed to sell its diagnostic-products business to Sekisui Chemical Co. for $265 million in cash.

To contact the editor responsible for this story: JoAnne Norton at jnorton@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.